一个基于mTBI临床概况的共同数据元素判断过程:一个有针对性的多领域临床试验初步研究
Kori J Durfee1, R J Elbin1, Alicia M Trbovich2
1Office for Sport Concussion Research, University of Arkansas, Fayetteville, AR 72701, USA.
Military medicine
|November 10, 2023
概括
这项研究发现,对偏头痛/头痛,前庭关节和焦虑/情绪的常见数据元素 (CDE) 对于识别轻度创伤性脑损伤 (mTBI) 概况是有用的. 在这项mTBI研究中,认知和眼部CDE的临床价值较低.
科学领域:
- 神经科学是一个神经科学.
- 临床医学 临床医学
- 公共卫生 公共卫生
背景情况:
- 轻度创伤性脑损伤 (mTBI) 是一个重大的公共卫生问题.
- 对mTBI临床概况的标准化评估对于有效的诊断和治疗至关重要.
- 联邦机构间创伤性脑损伤研究的共同数据元素 (CDEs) 旨在标准化mTBI研究.
研究的目的:
- 确定临床医生识别的mTBI临床概况和CDE截止分数的流行率和一致性.
- 评估CDE评估的预测价值,以确定成人mTBI临床概况.
主要方法:
- 71名患有mTBI的成年人完成了临床面试和多领域评估.
- 临床医生识别的mTBI概况与使用CDE评估识别的mTBI概况进行了比较.
- 逻辑回归分析确定了临床医生识别的mTBI概况的预测性CDE.
主要成果:
- 偏头痛/头痛,前体和焦虑/情绪概况显示出高患病率和临床医生和CDE识别之间的一致性.
- 特定的CDE (全球严重性指数,头痛影响测试-6) 预测了焦虑/情绪和偏头痛/头痛概况.
- 垂体/眼动力查和匹兹堡睡眠质量指数分别预测了垂体和睡眠概况.
结论:
- 对于偏头痛/头痛,前庭,焦虑/情绪和睡眠领域的CDE似乎在临床上有用,用于识别mTBI概况.
- 对于认知和眼部领域的CDE可能对mTBI配置识别具有有限的临床实用性.
- 标准化的CDE可以帮助一致识别mTBI临床概况.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
